Article

Comparison of Personal and Shared Frameshift Neoantigen Vaccines in a Mouse Mammary Cancer Model.

2020-04-01

Abstract excerpt

<title>Abstract</title> <p>Background: It is widely hoped that personal cancer vaccines will extend the number of patients benefiting from checkpoint and other immunotherapies. However, it is clear creating such vaccines will be challenging. It requires obtaining and sequencing tumor DNA/RNA, predicting potentially immunogenic neoepitopes and manufacturing a one-use vaccine. This process takes time and considerab...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: c4f780fe-4fc6-5740-8966-c44302222f8f
DOI: 10.21203/rs.2.23006/v2

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Comparison of Personal and Shared Frameshift Neoantigen Vaccines in a Mouse Mammary Cancer Model.DOI 10.21203/rs.2.23006/v2Read

Comparison of personal and shared frameshift neoantigen vaccines in a mouse mammary cancer model.Semantic proximity Read

Bedside formulation of a personalized multi-neoantigen vaccine against mammary carcinomaSemantic proximity Read

RNA Transcription and Splicing Errors as a Source of Cancer Frameshift Neoantigens for VaccinesSemantic proximity Read

Using Frameshift Peptide Arrays for Cancer Neo-Antigens ScreeningSemantic proximity Read

Personalized Cancer Vaccines Directed against Tumor Mutations: Building Evidence from Mice to Humans.Semantic proximity Read

Therapeutic Effects of a Neoantigen Vaccine With an Immune Checkpoint Inhibitor in a Cisplatin-Treated Mouse ModelSemantic proximity Read

Molecular targets and strategies in the development of nucleic acid cancer vaccines: from shared to personalized antigensSemantic proximity Read

A library of Neo Open Reading Frame peptides (NOPs) as a sustainable resource of common neoantigens in up to 50% of cancer patientsSemantic proximity Read

Targeting Mutated Plus Germline Epitopes Confers Pre-clinical Efficacy of an Instantly Formulated Cancer Nano-VaccineSemantic proximity Read

Synthetic multiepitope neoantigen DNA vaccine for personalized cancer immunotherapy.Semantic proximity Read

Recurrent Frameshift Neoantigen Vaccine Elicits Protective Immunity With Reduced Tumor Burden and Improved Overall Survival in a Lynch Syndrome Mouse ModelSemantic proximity Read

Neoantigen DNA vaccines are safe, feasible, and capable of inducing neoantigen-specific immune responses in patients with triple negative breast cancerSemantic proximity Read